Home > Medical Devices > mTPE Device Market Top share, Growth, Forecast to 2029
Straits Research

mTPE Device Market

mTPE Device Market: Information by Therapeutic Type (Bone Marrow, Renal Dialysis), Application (Cell Depletion, Granulocyte Collection), and End User, and Region — Forecast till 2029

Table of Content Download Sample

Market Overview

The global mTPE Device Market  is expected to grow at a 7.6% CAGR during the forecast period.

Therapeutic plasma exchange (mTPE) removes and replaces a patient’s blood plasma and can treat several autoimmune diseases. The antibodies in autoimmune diseases are known for attacking specific parts of the body and cause a spectrum of symptoms, depending on the target.

The process starts with the removal of plasma, which is then pumped through a large-pore membrane of the plasma filter. The growing prevalence of such autoimmune diseases is subsequently boosting the market growth, which is further grabbing the attention of several emerging players in the therapeutic plasma exchange (mTPE) device market. For instance, recently, Baxter—a pioneer and a single leader in the industry—introduced ‘PRISMAFLEX System,’ a flexible, filter-based solution that meets the demand of multiple therapies. The device is backed with a number of features including, accurate fluid management, streamlined alarm management, patented deaeration chamber, and innovative sterile solution. It is specially designed for providing healthcare professionals with more efficacy in the delivery of continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) therapies. Apart from this, supportive government regulations for reimbursement policies regarding healthcare and rising consolidation for healthcare amenities are adding fuel to the market growth.

Market Snapshot

market snapshot
Base Year
: 2021
Study Period
: 2017-2029
: 7.6 %
Fastest Growing Market
: Europe
Largest Market
: North America
Market Size
: USD Billion by 2029
Get more information on this report Download Sample Report

Market Dynamics

Factors Driving the mTPE Device Market

The rising prevalence of chronic diseases and intensive research and clinical trials are the factors contributing to the market growth. The players in the mTPE device market are arduously working to provide user-friendly devices with consolidated safety and low maintenance cost to patients across the globe. For the record, the mTPE device decreases the maintenance cost by choosing a membrane that complies with the individual patient requirements, which is further boosting the market growth.

Baxter to Lead the Overall Market

In the mTPE device market, Baxter manufactures highly specialized filtering blood purification therapies and ensures utmost patient safety. For nurses and clinicians, the ‘PRISMAFLEX System’ helps to save time by providing automatic adjustments allied with immediate visual feedback of the system’s status.

Segmental Analysis

The key segments of the mTPE device market the therapeutic application,  therapeutic types, and end-user.

By therapeutic application, the mTPE device market is segmented into plasma or red cell exchange, cell depletion, granulocyte collection, and stem cell collection. The stem cell collection segment is dominating the market and will continue the same during the forecast period.

On the basis of therapeutic type, the mTPE device market is segmented into hemophilia, bone marrow, platelet transfusion, and renal dialysis. The platelet transfusion is projected to capture a major market share with the highest CAGR.

By end-user, the mTPE device market is segmented into hospitals, research laboratories, blood banks, and blood transfusion laboratories. The hospital segment is leading the mTPE device market on account of increasing patient pool, rising prevalence of several diseases, and shifting preference towards technologically advanced medical treatments. The research laboratories segment is projected to increase at a significant pace during the forecast period.

Regional Analysis

North America is holding one of the largest shares in the global mTPE device market. The region is backed by the presence of leading industry players, increasing patient pool, and rising population. Moreover, rapid expansion and a surge in the number of research and academic institutions in the region are boosting the market growth. In addition, the Institutional Ethical Committee and Medical Research Councils are two such prominent research institutes in the market. Other factors driving the market growth include the rising prevalence of neurological diseases, increasing clinical response rate for therapeutic plasma exchange for the treatment of Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis, and growing prevalence of multiple sclerosis.

Europe is second in the global mTPE device market and will continue the same during the forecast period. This can be attributed to the well-equipped healthcare infrastructure, advanced medical technologies, and a high population base. The region is likely to emboss an impressive footprint in the overall mTPE device market in the years to come.

Asia Pacific is the fastest growing mTPE device market on account of raising awareness of diagnosis among the patients, rising expenditure power, government support, rising investments by leading players, and the presence of major players. The key markets gaining high profitability index include Japan, China, Australia, Singapore, and New Zealand. In the region, China is dominating the mTPE device market; whereas, India is expected to witness significant growth during the forecast period.

Furthermore, LAMEA is projected to witness steady growth during the forecast period.

mTPE Device Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of mTPE Device Market

Global mTPE device market has the presence of established players that are acquiring emerging players for expanding their portfolio and increasing their market share. Baxter is one of the major companies functional in the mTPE device market. It offers a wide range of product pipelines with continuous advancements and up-gradations to sustain in the cut-throat competition.

In 2013, Baxter acquired Gambro to expand its therapeutic product portfolio and geographical reach. Apart from this, raising awareness among the patients and physicians concerning the company’s products is further boosting the company's growth.

Report Scope

Report Metric Details
CAGR 7.6%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Therapeutic Application
    1. Plasma or red cell exchange
    2. Cell depletion
    3. Granulocyte collection
    4. Stem cell collection
  2. By Therapeutic Type
    1. Hemophilia
    2. Bone marrow
    3. Platelet transfusion
    4. Renal dialysis
  3. By End-User
    1. Hospitals
    2. Research Laboratories
    3. Blood bank
    4. Blood transfusion laboratories
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Recent Developments

On 11th February 2019: NantHealth and Baxter International Inc. announced that NantHealth digital Health Solution is now available to connect Baxter’s ‘Prismaflex system’ to a hospital Electronic Medical Record (EMR).Prismaflex is extensively used for treating patients in ICU with acute kidney injury (AKI) and certain life-threatening blood and autoimmune conditions.

mTPE Device Market Segmentation

By Therapeutic Application

  • Plasma or red cell exchange
  • Cell depletion
  • Granulocyte collection
  • Stem cell collection

By Therapeutic Type

  • Hemophilia
  • Bone marrow
  • Platelet transfusion
  • Renal dialysis

By End-User

  • Hospitals
  • Research Laboratories
  • Blood bank
  • Blood transfusion laboratories

By Region


  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America


  • Western Europe
    • U.K
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe


  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific


  • The Middle East
    • Saudi Arabia
    • UAE
    • Qatar
    • Rest of the Middle East
  • Africa
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers